Viona Pharmaceuticals recalled 3,960 bottles of Tavaborole Topical Solution on August 12, 2025. The product may show discoloration, posing health risks to consumers. This recall affects topical solutions distributed nationwide in the USA.
Discoloration
Consumers and healthcare providers should stop using this product immediately. Contact VIONA PHARMACEUTICALS INC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Tavaborole Topical Solution 5%, packaged in 10 mL glass bottles. The NDC is 72578-102-04, and the lot number is T401968.
The discoloration of the Tavaborole Topical Solution may indicate chemical instability. This poses potential health risks to consumers using the product.
No specific incidents have been reported in connection with this recall. The recall is classified as Class II due to the potential health risks associated with the discoloration.
Consumers should stop using the product immediately. Contact Viona Pharmaceuticals or a healthcare provider for further guidance.
For more information, contact Viona Pharmaceuticals Inc. at their Cranford, NJ office or visit their website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.